About 1 result found for searched term "Cergutuzumab amunaleukin" (0.122 seconds)
| Cat.No. | Name | Target |
|---|---|---|
| M24703 | Cergutuzumab amunaleukin | IL Receptor/Related |
| CEA-IL2v; RG 7813; RO 6895882 | ||
| Cergutuzumab amunaleukin (CEA-IL2v) is a monomeric carcinoembryonic antigen (CEA)-targeted IL-2 variant-based immunocytokine. Cergutuzumab amunaleukin has immunostimulating and antineoplastic activities. | ||
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.
